Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about Researchers Develop 3-D Printed Guide for Patients with Nerve Injury
A team of US researchers has developed 3D-printed guide that regrow both the sensory and motor functions of complex nerves after injury. The study was published in the journal Advanced Functional Materials.

[adsense:336x280:8701650588]
- Read more about Strides Arcolab acquires CNS divisions of erstwhile Ranbaxy
Sun Pharmaceutical Industries Ltd. and Strides Arcolab Ltd. have entered into a definitive agreement related to erstwhile Ranbaxy’s ‘Solus’ and ‘Solus Care’ divisions operating in the central nervous system (CNS) segment in India.
- Read more about Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial
Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and Eli Lilly and Company's (NYSE: LLY) Jardiance® (empagliflozin) significantly reduced the risk of the combined endpoint of cardiovascular (CV) death, non-fatal heart attack or non-fatal stroke by 14 percent when added to standard of care in patients with type 2 diabetes (T2D) at high risk of CV events. There was a 38 percent reduction in CV death, with no significant difference in the risk of non-fatal heart attack or non-fatal stroke.
- Read more about U.S. District Court Rules in Lilly's Favor on Alimta Vitamin Regimen Patent
Eli Lilly and Company (NYSE: LLY) today announced that the U.S. District Court for the Southern District of Indiana has ruled in the company's favor regarding infringement of the vitamin regimen patent for Alimta® (pemetrexed for injection).
- Read more about Novartis new heart failure medicine got Swiss approval
Novartis announced today that Swissmedic has approved Entresto(TM) (sacubitril/valsartan), previously known as LCZ696, to reduce the risk of cardiovascular mortality and morbidity in patients with heart failure with reduced ejection fraction (HFrEF). Entresto will be available on prescription for adult patients whose condition is classified NYHA class II-IV and with an ejection fraction of 40% or less. It is administered in combination with other heart failure therapies as appropriate, in place of an ACE inhibitor or angiotensin receptor blocker.
- Read more about Researchers found Skin Microbiome may Fight Common STDs
New research suggests that bacteria residing in our skin may help fight infections caused by chancroid, a sexually transmitted disease (STD). The findings suggest that skin microbiome can influence the outcomes of a bacterial infection. The study was published in the journal mBio.
- Read more about Novel Chocolate Made of Dietary Cocoa Extract Promote Brain Health in Elders
Scientists found that a novel chocolate made of dietary cocoa extract can promote brain health in the elderly. The paper was published in the Journal of Alzheimer's Disease.
- Read more about New Synthetic Method Act As Potential Treatment For Type 2 Diabetes
A new synthetic route to potential medicines for type 2 diabetes. The study appears in Chemistry - A European Journal.
- Read more about Granules India receive US FDA approval for ibuprofen tablets
Granules India, a Rs. 1,200 crore pharmaceutical major from Hyderabad, has received US FDA approval for ibuprofen tablets USP, 400 mg, 600 mg and 800 mg.
- Read more about AstraZeneca purchases US biologics manufacturing facility to support growing pipeline
AstraZeneca purchased high-tech biologics bulk manufacturing facility from Amgen Inc. Over time, the LakeCentre facility, located in Boulder, Colorado will increase manufacturing and production capacity to support the company’s extensive portfolio of biologics medicines.